Silicon Laboratories (NASDAQ:SLAB) Releases Q4 2025 Earnings Guidance

Silicon Laboratories (NASDAQ:SLAB) updated its fourth quarter 2025 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of 0.400-0.700 for the period, compared to the consensus estimate of 0.180. The company issued revenue guidance of -, compared to the consensus revenue estimate of $212.6 million.

Analyst Upgrades and Downgrades

A number of research firms have commented on SLAB. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Silicon Laboratories in a research note on Wednesday, October 8th. Susquehanna upped their price target on shares of Silicon Laboratories from $110.00 to $150.00 and gave the company a “neutral” rating in a research report on Tuesday, July 22nd. KeyCorp lifted their price objective on shares of Silicon Laboratories from $160.00 to $180.00 and gave the stock an “overweight” rating in a research report on Tuesday, July 8th. Stifel Nicolaus boosted their target price on shares of Silicon Laboratories from $144.00 to $160.00 and gave the company a “buy” rating in a research note on Friday, July 18th. Finally, Morgan Stanley decreased their target price on Silicon Laboratories from $157.00 to $144.00 and set an “equal weight” rating for the company in a research report on Wednesday, August 6th. Five equities research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $151.13.

Silicon Laboratories Stock Down 2.4%

Shares of SLAB opened at $127.96 on Tuesday. The firm has a market cap of $4.20 billion, a price-to-earnings ratio of -39.74 and a beta of 1.51. The company’s fifty day moving average is $133.87 and its 200-day moving average is $131.30. Silicon Laboratories has a 12 month low of $82.82 and a 12 month high of $160.00.

Silicon Laboratories (NASDAQ:SLAB) last announced its earnings results on Tuesday, August 5th. The semiconductor company reported $0.11 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.09 by $0.02. The firm had revenue of $192.85 million during the quarter, compared to analysts’ expectations of $192.57 million. Silicon Laboratories had a negative return on equity of 7.21% and a negative net margin of 14.88%.The company’s revenue was up 32.6% on a year-over-year basis. During the same quarter in the prior year, the business earned ($0.56) earnings per share. As a group, research analysts predict that Silicon Laboratories will post -0.97 earnings per share for the current fiscal year.

Insider Activity at Silicon Laboratories

In related news, SVP Brandon Tolany sold 8,000 shares of the company’s stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $145.23, for a total value of $1,161,840.00. Following the completion of the transaction, the senior vice president directly owned 62,328 shares in the company, valued at approximately $9,051,895.44. This represents a 11.38% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Insiders have sold a total of 12,070 shares of company stock worth $1,703,472 over the last three months. 1.60% of the stock is currently owned by corporate insiders.

Institutional Trading of Silicon Laboratories

Several institutional investors have recently bought and sold shares of the stock. Caxton Associates LLP acquired a new stake in shares of Silicon Laboratories in the 2nd quarter valued at $255,000. CANADA LIFE ASSURANCE Co lifted its holdings in Silicon Laboratories by 4.0% during the 2nd quarter. CANADA LIFE ASSURANCE Co now owns 33,258 shares of the semiconductor company’s stock valued at $4,899,000 after purchasing an additional 1,269 shares during the last quarter. Tower Research Capital LLC TRC boosted its position in Silicon Laboratories by 116.1% in the second quarter. Tower Research Capital LLC TRC now owns 4,146 shares of the semiconductor company’s stock valued at $611,000 after buying an additional 2,227 shares in the last quarter. Corient Private Wealth LLC bought a new stake in Silicon Laboratories during the second quarter worth about $363,000. Finally, Vident Advisory LLC bought a new stake in Silicon Laboratories during the second quarter worth about $325,000.

About Silicon Laboratories

Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.